Publication: 2606

Publication: 2606

Final Results of a phase III trial of celecoxib (C) in addition to standard chemotherapy for advanced NSCLC with COX- 2 overexpression: CALGB 30801 (Alliance)

URL

Google Scholar

Citation:: Int J Radiat Oncol Biol Phys vol 98 (1) 220-1

Meeting Instance:: MSTO 2017
Year:: 2017
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 2600

Program:: OGC
Primary Committee:: Respiratory
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882

Corr. Author:
Authors:: Martin J. Edelman Xiaofei Wang Lydia Hodgson Richard T. Cheney Maria Q. Baggstrom Thomas Sachdev Ajeet Gajra Erin Bertino Karen L. Reckamp Julian Molina Joan Schiller Kisha Mitchell-Richards Paula N. Friedman Jon Ritter Ginger Milne Olwen Hahn Thomas Stinchcombe Everett E. Vokes

Networks:: CA043, LAPS-IL036, LAPS-IL057, LAPS-MN026, LAPS-MO011, LAPS-NC010, MD015, NY175, OH008, VA002

Study: CALGB-30801
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: